(AP-Business Wire) Israel's Pi-Cardia Ltd., developer of non-implant, catheter-based solutions for treating heart valves, announced Thursday its first successful treatment of human patients with its ShortCut device at Shaare Zedek Medical Center in Jerusalem. "Using ShortCut, we were able to treat two extremely complex patients with degenerated valves," enabling safe transcatheter aortic valve replacement, said Dr. Danny Dvir, who performed the procedure.
2021-01-14 00:00:00Full ArticleBACK Visit the Daily Alert Archive